Lim, J. K., Liapakis, A. M., Shiffman, M. L., Lok, A. S., Zeuzem, S., Terrault, N. A., . . . Ben-Ari, Z. (2018). Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients with Genotype 1 Hepatitis C Virus Infection and Cirrhosis. Clin Gastroenterol Hepatol.
Citação norma ChicagoLim, Joseph K., et al. "Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis." Clin Gastroenterol Hepatol 2018.
Deismireacht MLALim, Joseph K., et al. "Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis." Clin Gastroenterol Hepatol 2018.